495 related articles for article (PubMed ID: 32188379)
21. Targeting Nanomedicines to Prostate Cancer: Evaluation of Specificity of Ligands to Two Different Receptors In Vivo.
Pearce AK; Fuchs AV; Fletcher NL; Thurecht KJ
Pharm Res; 2016 Oct; 33(10):2388-99. PubMed ID: 27225496
[TBL] [Abstract][Full Text] [Related]
22. Recent Progress and Challenges in Clinical Translation of Nanomedicines in Diagnosis and Treatment of Lung Cancer.
Yadav B; Chauhan M; Singh RP; Sonali ; Shekhar S
Curr Drug Targets; 2024; 25(1):12-24. PubMed ID: 38058096
[TBL] [Abstract][Full Text] [Related]
23. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
Koning GA; Krijger GC
Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
[TBL] [Abstract][Full Text] [Related]
24. Nanomedicines for Reactive Oxygen Species Mediated Approach: An Emerging Paradigm for Cancer Treatment.
Kwon S; Ko H; You DG; Kataoka K; Park JH
Acc Chem Res; 2019 Jul; 52(7):1771-1782. PubMed ID: 31241894
[TBL] [Abstract][Full Text] [Related]
25. Tumor microenvironment and nanotherapeutics: intruding the tumor fort.
Ravi Kiran AVVV; Kusuma Kumari G; Krishnamurthy PT; Khaydarov RR
Biomater Sci; 2021 Nov; 9(23):7667-7704. PubMed ID: 34673853
[TBL] [Abstract][Full Text] [Related]
26. Polymeric nanoparticles for targeted treatment in oncology: current insights.
Prabhu RH; Patravale VB; Joshi MD
Int J Nanomedicine; 2015; 10():1001-18. PubMed ID: 25678788
[TBL] [Abstract][Full Text] [Related]
27. From Passive Targeting to Personalized Nanomedicine: Multidimensional Insights on Nanoparticles' Interaction with the Tumor Microenvironment.
Sebak AA; El-Shenawy BM; El-Safy S; El-Shazly M
Curr Pharm Biotechnol; 2021; 22(11):1444-1465. PubMed ID: 33308126
[TBL] [Abstract][Full Text] [Related]
28. Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging.
Glasgow MD; Chougule MB
J Biomed Nanotechnol; 2015 Nov; 11(11):1859-98. PubMed ID: 26554150
[TBL] [Abstract][Full Text] [Related]
29. Nanomedicine for cancer diagnosis and therapy: advancement, success and structure-activity relationship.
Bhise K; Sau S; Alsaab H; Kashaw SK; Tekade RK; Iyer AK
Ther Deliv; 2017 Nov; 8(11):1003-1018. PubMed ID: 29061101
[TBL] [Abstract][Full Text] [Related]
30. Research progress of novel inorganic nanometre materials carriers in nanomedicine for cancer diagnosis and treatment.
Xu J; Liao K; Jiang H; Zhou W
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S492-S502. PubMed ID: 30449177
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic efficacy of nanomedicines for prostate cancer: An update.
Lakshmanan VK
Investig Clin Urol; 2016 Jan; 57(1):21-9. PubMed ID: 26966723
[TBL] [Abstract][Full Text] [Related]
32. Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers.
Aghebati-Maleki A; Dolati S; Ahmadi M; Baghbanzhadeh A; Asadi M; Fotouhi A; Yousefi M; Aghebati-Maleki L
J Cell Physiol; 2020 Mar; 235(3):1962-1972. PubMed ID: 31441032
[TBL] [Abstract][Full Text] [Related]
33. Reduction-sensitive polymeric nanomedicines: An emerging multifunctional platform for targeted cancer therapy.
Sun H; Zhang Y; Zhong Z
Adv Drug Deliv Rev; 2018 Jul; 132():16-32. PubMed ID: 29775625
[TBL] [Abstract][Full Text] [Related]
34. Copolymers of poly(lactic acid) and D-α-tocopheryl polyethylene glycol 1000 succinate-based nanomedicines: versatile multifunctional platforms for cancer diagnosis and therapy.
Vijayakumar MR; Muthu MS; Singh S
Expert Opin Drug Deliv; 2013 Apr; 10(4):529-43. PubMed ID: 23316695
[TBL] [Abstract][Full Text] [Related]
35. Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer.
Rajabi M; Adeyeye M; Mousa SA
Curr Med Chem; 2019; 26(30):5664-5683. PubMed ID: 31250748
[TBL] [Abstract][Full Text] [Related]
36. Nanomedicines functionalized with anti-EGFR ligands for active targeting in cancer therapy: Biological strategy, design and quality control.
Nguyen PV; Allard-Vannier E; Chourpa I; Hervé-Aubert K
Int J Pharm; 2021 Aug; 605():120795. PubMed ID: 34119579
[TBL] [Abstract][Full Text] [Related]
37. New Strategies in Cancer Nanomedicine.
Tong R; Kohane DS
Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
[TBL] [Abstract][Full Text] [Related]
38. Polymeric nanomedicine for cancer MR imaging and drug delivery.
Khemtong C; Kessinger CW; Gao J
Chem Commun (Camb); 2009 Jun; (24):3497-510. PubMed ID: 19521593
[TBL] [Abstract][Full Text] [Related]
39. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
[TBL] [Abstract][Full Text] [Related]
40. Novel therapeutic interventions in cancer treatment using protein and peptide-based targeted smart systems.
Zafar S; Beg S; Panda SK; Rahman M; Alharbi KS; Jain GK; Ahmad FJ
Semin Cancer Biol; 2021 Feb; 69():249-267. PubMed ID: 31442570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
